Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 1.02TCr 150.65Cr 131.66Cr 121.49Cr 111.98Cr 211.07Cr 15TCr 215.75Cr 1.45TCr 571.15Cr 7.11TCr 565.78Cr 553.37Cr 24TCr P/E 2026 *
15.2x
P/E 2027 * 12.6x
Enterprise Value 1.02TCr 150.65Cr 131.66Cr 121.49Cr 111.98Cr 211.07Cr 15TCr 215.75Cr 1.45TCr 571.15Cr 7.11TCr 565.78Cr 553.37Cr 24TCr EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.15x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-3.23%
1 week+1.89%
Current month+9.57%
1 month+4.92%
3 months-4.32%
6 months-15.69%
Current year-15.39%
1 week 23.65
Extreme 23.65
24.69
1 month 21.22
Extreme 21.22
24.69
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%+1.89%-15.69%-8.07% 150.65Cr
+0.85%-0.80%+52.79%+159.97% 1,05100Cr
+1.23%-1.53%+54.58%+59.41% 61TCr
+0.04%+2.58%+34.47%+84.84% 45TCr
+0.78%-0.71%+29.28%+23.25% 33TCr
+1.41%+0.58%+35.44%+40.53% 28TCr
-0.27%-1.87%+22.34%+19.92% 26TCr
-1.76%+2.37%-20.43%-38.01% 22TCr
-1.42%+0.80%+24.27%+57.85% 20TCr
-1.48%+3.43%+24.08%+70.06% 17TCr
Average -0.38%+0.33%+24.11%+46.97% 35.77TCr
Weighted average by Cap. +0.37%+0.02%+37.49%+78.72%

Financials

2026 *2027 *
Net sales 431.8Cr 64Cr 56Cr 51Cr 47Cr 89Cr 6.13TCr 91Cr 614.02Cr 241.51Cr 3TCr 239.24Cr 233.99Cr 10TCr 475.4Cr 70Cr 61Cr 57Cr 52Cr 98Cr 6.75TCr 100.44Cr 676.02Cr 265.89Cr 3.31TCr 263.4Cr 257.62Cr 11TCr
Net income 67Cr 9.94Cr 8.69Cr 8.02Cr 7.39Cr 14Cr 957.59Cr 14Cr 96Cr 38Cr 468.99Cr 37Cr 37Cr 1.61TCr 74Cr 11Cr 9.61Cr 8.86Cr 8.17Cr 15Cr 1.06TCr 16Cr 105.94Cr 42Cr 518.39Cr 41Cr 40Cr 1.78TCr
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
17/26/17 CN¥23.69 -3.23% 93,64,235
16/26/16 CN¥24.48 +0.41% 1,09,30,092
15/26/15 CN¥24.38 +1.33% 84,27,800
14/26/14 CN¥24.06 -0.04% 88,80,000
13/26/13 CN¥24.07 +3.53% 1,05,94,547
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.69CNY
Average target price
36.25CNY
Spread / Average Target
+53.02%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock